Infecciones neonatales por Streptococo grupo B

1. Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013;31(suppl 4):D3–D6.

2. Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013;31(suppl 4):D20–D26.

3. Berardi A, Rossi C, Lugli L, et al; GBS Prevention Working Group, EmiliaRomagna. Group B streptococcus late-onset disease: 2003-2010. Pediatrics. 2013;131:e361–e368.

4. Edwards MS, Rench MA, Baker CJ. Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. Pediatr Infect Dis J. 2015;34:538–539.

5. MacFarquhar JK, Jones TF, Woron AM, et al. Outbreak of late-onset group B streptococcus in a neonatal intensive care unit. Am J Infect Control. 2010;38:283–288.

6. Davanzo R, De Cunto A, Travan L, et al. To feed or not to feed? Case presentation and best practice guidance for human milk feeding and group B streptococcus in developed countries. J Hum Lact. 2013;29:452–457.

7. Le Doare K, Kampmann B. Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection? Vaccine. 2014;32:3128–3132.

8. Filleron A, Lombard F, Jacquot A, et al. Group B streptococci in milk and late neonatal infections: an analysis of cases in the literature. Arch Dis Child Fetal Neonatal Ed. 2014;99:F41–F47.

9. Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine. 2013;31(suppl 4):D7–D12.

10. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-11):1–32.

11. Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2014:1–17.

12. Berardi A, Lugli L, Rossi C, et al; GBS Prevention Working Group. Impact of perinatal practices for early-onset group B Streptococcal disease prevention. Pediatr Infect Dis J. 2013;32:e265–e271.

13. Verani JR, Spina NL, Lynfield R, et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol. 2014;123:828–837.

14. Bekker V, Bijlsma MW, van de Beek D, et al. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis. 2014;14:1083–1089.

15. Lamagni TL, Keshishian C, Efstratiou A, et al. Emerging trends in the epidemiology

of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis. 2013;57:682–688.

16. Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013;31(suppl 4):D31–D42.

17. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and metaanalysis. Lancet. 2012;379:547–556.

18. Johri AK, Lata H, Yadav P, et al. Epidemiology of group B streptococcus indeveloping countries. Vaccine. 2013;31(suppl 4):D43–D45.

19. Springman AC, Lacher DW, Wu G, et al. Selection, recombination, and virulence gene diversity among group B streptococcal genotypes. J Bacteriol.

2009;191:5419–5427.

20. Creti R, Berardi A, Baldassarri L, et al; GBS Prevention Working Group, Emilia-Romagna and the Neonatal GBS Italian network. Characteristics of neonatal GBS disease during a multicentre study (2007-2010) and in the year 2012. Ann Ist Super Sanita. 2013;49:370–375.

21. Berardi A, Lugli L, Baronciani D, et al; GBS Prevention Working Group of Emilia-Romagna. Group B streptococcus early-onset disease in Emilia romagna: review after introduction of a screening-based approach. Pediatr Infect Dis J. 2010;29:115–121.

22. Imperi M, Pataracchia M, Alfarone G, et al. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods. 2010;80:212–214.

23. Creti R, Fabretti F, Orefici G, et al. Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes. J Clin Microbiol. 2004;42:1326–1329.

24. Imperi M, Gherardi G, Berardi A, et al. Invasive neonatal GBS infections from an area-based surveillance study in Italy. Clin Microbiol Infect. 2011;17:1834–1839.

25. Montanari MP, Mingoia M, Giovanetti E, et al. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci. J Clin Microbiol. 2001;39:1311–1315.